A needless addition to the other macrolides

Prescrire International

Volumn 12, Issue 63, 2003, Pages 8-11

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ATORVASTATIN; BETA LACTAM ANTIBIOTIC; CEFUROXIME AXETIL; CISAPRIDE; CLARITHROMYCIN; CYTOCHROME P450 ISOENZYME; ERGOT ALKALOID; ERYTHROMYCIN DERIVATIVE; MACROLIDE; PENICILLIN V; PIMOZIDE; SIMVASTATIN; SPIRAMYCIN; TELITHROMYCIN; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CHRONIC BRONCHITIS; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS RESISTANCE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; ENZYME INHIBITION; EYE INFECTION; FRANCE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; LIVER DISEASE; MEDICAL DECISION MAKING; NECROSIS; NONHUMAN; NOSE INFECTION; PHARYNGITIS; PNEUMONIA; PRESCRIPTION; RHABDOMYOLYSIS; RISK ASSESSMENT; SINUSITIS; STREPTOCOCCUS PNEUMONIAE; TONSILLITIS; TORSADE DES POINTES; TREATMENT OUTCOME; VERTIGO; VISUAL DISORDER;

EID: 0038277198     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Prescrire Editorial Staff "Fluoroquinolones in ambulatory ENT and respiratory tract infections" Prescr Int 2003; 12 (63): 26-27.
2. "Pharyngitis". In: "Martindale The Complete Drug Reference" 33rd ed, The Pharmaceutical Press, London 2002: 134-135.
3. "Macrolides". In: "Martindale The Complete Drug Reference" 33rd ed, The Pharmaceutical Press, London 2002: 112.
4. Prescrire Editorial Staff "Choosing a macrolide" Prescr Int 1999; 8 (44): 183-187.
5. The European Agency for the Evaluation of Medicinal Products - Committee for Proprietary Medicinal Products - European Public Assessment Report "Telithromycine version 2" London 2001: 59 pages.
6. FDA Briefing Package. Anti-infective drugs advisory Committee "New Drug Application (NDA) 21-144. Ketek (Telithromycine)" April 26th 2001: 92 pages.
7. Buchanan P et al. "A 5-day course of telithromycin (TEL), the first ketolide antibacterial is as effective as 10 days' cefuroxime axetil (CXM) in the treatment of acute maxillary sinusitis (AMS)" ICAAC 2001; abstr. 910 (1 page).
8. Roos K et al. "Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis" Chemotherapy 2002; 48 (2): 100-108.
9. Norrby SR et al. "Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treatment of pharyngitis/tonsillitis" Scand J Infect Dis 2001; 33 (12): 883-890.
10. Aubier M et al. "Telithromycin is highly effective in the treatment of community-acquired respiratory tract infections caused by Streptococcus pneumoniae with reduced penicillin and/or macrolid susceptibility" ICAAC 2001; abstr. 860 (1 page).
11. Agence française de sécurité sanitaire des produits de santé "Ketek - Résumé des caractéristiques" 23 June 2002.
12. French datasheet compendium "Macrolides". In: "Interactions médicamenteuses" Vidal, Paris 2002: 35-38.
13. Douthwaite S "Structure-activity relationships of ketolides versus macrolides" Clin Microbiol Infect 2001; 7 (suppl. 3): 11-17.
14. Prescrire Rédaction "Profil d'effets indésirables - les fluoroquinolones" Rev Prescr 2002; 22 (231): 610-611.